Inside the research
Option Care Health, Inc.
OPCH Research profile · latest available data
Price overview
$23.07
▲ +0.13 (+0.6%)
| 52w hi | $36.59 |
|---|---|
| 52w lo | $19.52 |
| Vol | 1.17M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.04
| Short | -0.25 |
|---|---|
| Medium | +0.05 |
| Long | +0.18 |
computed 2026-09-27
Key fundamentals
Option Care Health, Inc.
Healthcare · Medical Care Facilities
| Market cap | $3.46B |
|---|---|
| Enterprise value | $4.53B |
| Trailing P/E | 17.48x |
| Forward P/E | 11.08x |
| EV / EBITDA | 11.18x |
| P / S (ttm) | 0.61x |
| Profit margin | 3.7% |
| Return on equity | 16.0% |
| Revenue growth | +1.9% |
| Earnings growth | +12.9% |
| Debt / equity | 100.65 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.23 | |
| Sector | +0.08 | |
| Technical | -0.16 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
Risk Metrics
| Beta vs SPX | 0.31 |
|---|---|
| Corr SPX | 0.12 |
| Annual vol | 41.1% |
| Annual ret | -7.3% |
| Sharpe | -0.18 |
| Max DD | -46.7% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-29 | Earnings Release, Exhibits | read |
| 2026-05-22 | Shareholder Vote | read |
| 2026-05-12 | Reg FD Disclosure, Exhibits | read |
| 2026-05-05 | Officer / Director Change | read |
| 2026-04-30 | Earnings Release, Reg FD Disclosure… | read |
| 2026-04-02 | Material Agreement, Material Obligation… | read |
| 2026-02-24 | Earnings Release, Exhibits | read |
| 2026-01-12 | Earnings Release, Reg FD Disclosure… | read |
| 2025-10-30 | Earnings Release, Exhibits | read |
| 2025-09-25 | Material Agreement, Material Obligation… | read |
| 2025-08-20 | Officer / Director Change, Reg FD Disclosure… | read |
| 2025-07-30 | Earnings Release, Exhibits | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 8 |
| Top-5 share | 98.1% |
| HHI | 2,588 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $128.75M | 6.14M |
| Citadel Advisors | $56.19M | 2.68M |
| Millennium Management | $54.92M | 2.62M |
| Fidelity / FMR LLC | $38.15M | 1.82M |
| Capital Research / Capital World | $26.43M | 1.26M |
| AQR Capital Management | $3.57M | 170.16K |
| Bridgewater Associates | $2.31M | 110.29K |
| T. Rowe Price Group | $4.61K | 219.65K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2009–2025 · 16 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $4.30B | +13.9% | |
| Gross profit | $981.22M | +13.0% | |
| Operating income | $314.60M | +39.8% | |
| Net income | $267.09M | +30.5% | |
| Cash from ops | $258.45M | +27.5% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $22.82 | $23.15 | $22.72 | $23.07 | 1.17M |
| Sep 24 | $23.31 | $23.52 | $22.83 | $22.94 | 1.46M |
| Sep 23 | $23.88 | $24.14 | $23.27 | $23.34 | 1.33M |
| Sep 22 | $24.04 | $24.48 | $23.88 | $23.90 | 2.14M |
| Sep 21 | $24.30 | $24.38 | $23.81 | $23.95 | 3.12M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →